Kerecis and the US Department of Defence have entered an agreement to develop fish skin burn...

Chinese pharmaceutical company Chengdu Kanghong Pharmaceutical Group has announced its intention to acquire the remaining 7% stake in a pharmaceutical unit based in Chengdu,...

Cytokinetics’ new heart failure drug, Omecamtiv Mecarbil (OM), will have to target patient subgroups in order to succeed in the crowded heart failure market, says GlobalData in its recent...

ATCC and BioAgilytix have entered a partnership to develop assay systems, which can be used for testing drug potency, stability testing and other...

RXi Pharmaceuticals plans to expand its product pipeline and enter the immuno-oncology market by acquiring all the outstanding shares of cancer immunotherapies developer...

Nordic Nanovector ASA and LegoChem Biosciences have entered an agreement to include CD37-targeting antibody drug conjugates to non-radionuclide cancer...

The global market for major depressive disorder (MDD) is anticipated to grow at a substantial compound annual growth rate (CAGR) of 6.1% over the next ten years, according to a report by...

The percutaneous coronary interventions market is projected to grow at a steady compound annual growth rate of 3.5% globally, according to a report by...

ClearLight Diagnostics and Oregon Health and Science University Centre for Spatial Systems Biomedicine (OCSSB) have entered a co-development agreement to analyse the tumour micro-environment...

Peakdale Molecular and Cresset BioMolecular Discovery have entered an agreement to further expand the former’s integrated drug discovery...

Kadmon Holdings has dosed the first patient under a Phase 2 clinical trial of KD025, which is its rho-associated coiled-coil kinase 2 (ROCK2) inhibitor to treat chronic graft-versus-host...

Merck & Co and JenKem Technology have entered a distribution agreement to make Jenkem’s polyethylene glycol (PEG) products available for biomedical...

Rapid changes such as the launch of new biologic therapies and novel drugs, increasing number of patients, and advancements in imaging techniques to facilitate drug development will drive...

Allergan plans to expand its gastrointestinal research and development (R&D) pipeline and strengthen its position in non-alcoholic steatohepatitis through the acquisition of Tobira...

Venaxis plans to expand its business through its recent acquisition of BiOptix Diagnostics, a medical device...

Circle Pharma and Pfizer have entered an agreement to develop a screening library of macrocyclic...

Ophthalmology is set to witness a breakthrough due to increasingly promising products that are currently in pipeline, says a report by GBI...

US-based biopharmaceutical company Lexicon has reported positive top-line results from its pivotal Phase III Tandem1 trial of sotagliflozin to treat type 1 diabetes on a background of...

The attention deficit hyperactivity disorder (ADHD) market is projected to grow at a compound annual growth rate (CAGR) of 8.5% during 2014 to 2024 to reach a value of $13.9bn by 2024, according...

Asahi Glass has acquired Biomeva from Biomeva Holding to expand its...

Cynata Therapeutics and Fujifilm Corporation have entered a term sheet for the development and commercialisation of a Cynata technology and its product...